Dihexa

What it is

Dihexa (also called PNB-0408) is a synthetic six-carbon angiotensin IV analog with structural modifications intended to confer oral bioavailability and CNS penetration. It was developed at Washington State University by Joseph Harding and colleagues based on research into angiotensin IV signaling in the hippocampus and other brain regions. Dihexa is not FDA-approved for any use in the United States.

The compound has been promoted in some circles as a cognitive enhancer based on preclinical research in animal models. These claims have substantially outpaced the available evidence, as human data are essentially absent.

Mechanism of action

Proposed mechanisms come from laboratory and animal research:

• Hepatocyte growth factor (HGF) potentiation: in laboratory studies, Dihexa was reported to potentiate the binding of HGF to its receptor c-Met, a pathway involved in synaptic plasticity and dendritic complexity
• Synaptogenesis: animal studies reported increases in dendritic spine density in hippocampal neurons
• Cognitive measures in animal models: rodent studies reported changes in performance on spatial learning and memory tasks

Clinical evidence

Human clinical trial evidence on Dihexa is essentially absent. The compound has been characterized in preclinical studies but has not progressed to substantial human clinical research. Well-controlled human trials establishing its effectiveness and safety are lacking.

Why we don’t prescribe it at The Tide

The Tide does not prescribe Dihexa:

• Available evidence is limited to laboratory and animal studies
• Its effects on cognition and its safety in people are unknown
• Specific cognitive concerns warrant appropriate medical evaluation

Dihexa remains an experimental research compound.

Side effects and contraindications

Human safety data are essentially absent, and long-term effects are unknown. There are theoretical concerns about HGF signaling in cancer contexts, since HGF/c-Met signaling supports some malignancies. Products sold outside regulated channels (e.g., “research peptides”) may vary in purity, dose, and sterility.